The Minnesota-based Vaccine Integrity Project followed through Tuesday on a promise to provide scientific data on vaccine ...

With cases peaking during monsoon seasons and threatening infants and seniors, prevention through vaccination is more important than ever.

When the market becomes turbulent, investors tend to move away from high-growth, volatile stocks and toward companies with ...

In the third part of his Pharma Commerce video interview, Mark Lee, MarqVision’s founder and CEO, describes how AI-driven surveillance and image recognition vastly outpace traditional brand protection ...

After an unusual first quarter in which seven of the biopharma industry’s | Several U.S. pharma companies that had posted ...

The American Academy of Pediatrics breaks with federal guidance, urging COVID shots for young kids as Kennedy's panel delays ...

Pigot most recently served as chief commercial officer at Aerovate Therapeutics, which was developing a dry powder inhaled ...

Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, ...

The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.

BBIO's Acoramidis shows promise but faces tough competition. Diverse pipeline & catalysts ahead, but valuation relies on ...

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...

One of the highest yields you can get right now is from Pfizer (NYSE: PFE). The healthcare giant offers a yield of 6.8%, ...